Definition:Supplementary disclosure letter
📨 Supplementary disclosure letter is an additional disclosure document delivered by the seller after the original disclosure letter has been signed, updating or supplementing the information previously disclosed against the warranties in a share purchase agreement. In insurance transactions, where the period between signing and closing can be extended — particularly when change of control approvals from prudential regulators in multiple jurisdictions must be obtained — events may occur in the interim that materially affect the target insurer: a significant reserve deterioration, a new regulatory inquiry, a major catastrophe loss, or the departure of key underwriting personnel. The supplementary disclosure letter allows the seller to bring these developments to the buyer's attention formally.
⚙️ Whether the buyer is obligated to accept supplementary disclosures — and, critically, whether such disclosures limit the buyer's right to bring a warranty claim or invoke a material adverse change clause — depends entirely on the terms negotiated in the SPA. In buyer-friendly deals, the seller may deliver supplementary disclosures for information only, without prejudice to the buyer's remedies; in seller-friendly structures, accepted supplementary disclosures may update the disclosure letter and prevent the buyer from claiming on the relevant warranty. Insurance transactions tend to involve heightened negotiation on this point because the insurer's risk profile can shift markedly between signing and closing — a single catastrophe event or reserving exercise can alter the target's financial position in ways that are qualitatively different from the changes a typical non-insurance target might experience. The mechanics for delivery — timing, format, and the buyer's right to review and object — are set out either in the SPA itself or in a protocol agreed as part of the closing conditions.
💡 The supplementary disclosure letter sits at the intersection of information rights and deal risk allocation, making it one of the more contentious elements of insurance M&A documentation. For the buyer, unrestricted supplementary disclosure rights in the seller's hands would allow the seller to erode the warranty protection that the buyer negotiated at signing — effectively permitting the seller to disclose away claims that emerge in the gap period. For the seller, the inability to make supplementary disclosures creates the risk that innocent, ordinary-course developments trigger warranty liability or give the buyer a pretext to renegotiate or walk away. Sophisticated insurance deals often reach a middle ground: the seller may deliver supplementary disclosures, but if they reveal a matter that crosses a defined materiality threshold, the buyer obtains the right to terminate the SPA or seek a purchase price adjustment, preserving the commercial balance struck at signing.
Related concepts: